glp 1 on medicaid Pennsylvania stopped covering GLP-1s for obesity this year, but it's not all savings More state Medicaid programs may
Description
Novo Nordisk Headquarters: Bagsvrd, Denmark Number of employees: 77,000 Year founded: 1923 Revenue (2025): $42.1 billion Forbes overall rank: 42 In 2025, Novo Nordisk reported full-year sales of about DKK 309.1 billion (roughly $45 billion), a ~6% increase in Danish kroner and ~10% at constant exchange rates, driven mainly by obesity and diabetes semaglutide products Wegovy and Ozempic, though operating profit growth was modest and weighed down by transformation costs and pricing pressures

Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule

Data availability The data used in this meta-analysis were extracted from publicly available sources, including published randomized controlled trials

Is This Normal on GLP-1

Clinical trial evidence consistently shows that GLP-1RA therapy results in significant reductions in fat mass, accompanied by smaller but measurable decreases in lean mass